| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2839666 | Clínica e Investigación en Arteriosclerosis | 2012 | 9 Pages |
Abstract
CABG patients possess a lower number of CD34+/CD144+ cells than valvular ones. Plasma from CABG patients is antiapoptotic for EOCs from healthy donors and increases the expression of both CD34 and CD144. Suboptimal number of CD34+/CD144+ in vivo may be mediated by a primary bone marrow defect rather than a deleterious effect of plasma.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Physiology
Authors
Marta Ramajo, Santiago Redondo, Álvaro González-Rocafort, Jorge Navarro-Dorado, Fernando Reguillo, Manuel Carnero, José MartÃnez-González, Enrique RodrÃguez, Teresa Tejerina,